Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02883439 |
|
Recruitment Status :
Withdrawn
(no available patients)
First Posted : August 30, 2016
Last Update Posted : July 13, 2021
|
Sponsor:
University Hospital, Ghent
Collaborators:
MEDA Pharma GmbH & Co. KG
University of Wuerzburg
Information provided by (Responsible Party):
University Hospital, Ghent
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Actual Primary Completion Date : | March 2020 |
| Actual Study Completion Date : | March 2020 |